Clearstone Central Laboratories and LabCorp Establish Global Strategic Collaboration for Clinical Trials

Clearstone Central Laboratories

announced a global collaboration with Laboratory Corporation of America® Holdings (LabCorp®) through its Esoterix Clinical Trials Services division, providing clients with access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.  This global collaboration will deliver safety, diagnostic and specialty testing services in support of drug development and clinical trials. In addition, clients of each company will be able to access LabCorp’s industry-leading assay portfolio and Clearstone’s central laboratory protocol management system APOLLO CLPM™.